{
    "nct_id": "NCT03125226",
    "official_title": "TraceIT TM Hydrogel Tissue Marker for Patients Receiving Definitive Chemoradiation for Bladder Cancer",
    "inclusion_criteria": "* Histologically confirmed malignancy of the bladder\n* No prior cystectomy\n* Treatment plan for bladder must include at least 4 weeks of daily radiation treatment (most patients will receive chemotherapy concurrent with radiation, but this is not required for trial enrollment)\n* Patient must undergo TraceIT hydrogel placement within 8 weeks prior to starting radiation therapy for bladder cancer\n* Participants must have a complete history and physical examination within 60 days of study entry\n* Participants must be able to provide informed consent for treatment and trial participation\n* No restrictions on prior treatment to be eligible\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Prior cystectomy\n* Unable to have TraceIT hydrogel placement < 8 weeks prior to beginning radiation treatment\n* Treatment for metastatic bladder cancer",
    "miscellaneous_criteria": ""
}